Literature DB >> 24038533

Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation.

Valerie H Lau1, Rony Aouad, D Gregory Farwell, Paul J Donald, Allen M Chen.   

Abstract

BACKGROUND: The purpose of this study was to analyze the pattern of occult cervical lymph node metastasis among patients with clinically N0 salivary gland carcinoma.
METHODS: One hundred nineteen patients underwent primary surgery and ipsilateral neck dissection for clinically N0 carcinomas of the major and minor salivary glands. Eighty patients (67%) had parotid tumors. Distribution of T classification was: T1 (18%), T2 (28%), T3 (23%), and T4 (32%).
RESULTS: Twenty-five patients (21%) had pathological cervical disease. The incidence was highest among patients with adenocarcinoma (35%) and high-grade mucoepidermoid carcinoma (35%). The most common site of cervical lymph node metastasis was level II (71%), followed by level III (15%), and level IB (8%). On multivariate analysis, histological subtype was independently predictive of occult pathological lymph node metastasis (p < .001).
CONCLUSION: The likelihood of occult cervical lymph node metastasis for patients with salivary gland carcinoma is driven predominantly by histological subtype. Implications for elective neck irradiation are discussed.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  carcinoma; elective; irradiation; nodal involvement; salivary gland

Mesh:

Year:  2014        PMID: 24038533     DOI: 10.1002/hed.23467

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  16 in total

1.  Patterns of lymph node metastasis and the management of neck dissection for parotid carcinomas: a single-institute experience.

Authors:  Tsuyoshi Jinnin; Ryo Kawata; Masaaki Higashino; Shuji Nishikawa; Tetsuya Terada; Shin-Ichi Haginomori
Journal:  Int J Clin Oncol       Date:  2019-02-09       Impact factor: 3.402

2.  Neck dissection for salivary gland malignancies.

Authors:  Serena Byrd; Luc G T Morris
Journal:  Oper Tech Otolayngol Head Neck Surg       Date:  2018-07-03

Review 3.  Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy.

Authors:  Young Min Park; Yoon Woo Koh
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

4.  Postoperative radiation therapy for parotid mucoepidermoid carcinoma.

Authors:  Meghan P Olsen; Allen O Mitchell; Edward F Miles
Journal:  Case Rep Oncol Med       Date:  2014-12-14

5.  Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

Authors:  A D Jensen; M Poulakis; V Vanoni; M Uhl; N Chaudhri; P A Federspil; K Freier; J Krauss; J Debus
Journal:  Radiat Oncol       Date:  2016-07-07       Impact factor: 3.481

6.  Probability and pattern of occult cervical lymph node metastases in primary parotid carcinoma.

Authors:  Dominik Stodulski; Bogusław Mikaszewski; Hanna Majewska; Piotr Wiśniewski; Czesław Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-28       Impact factor: 2.503

Review 7.  Management of salivary gland carcinomas - a review.

Authors:  Xiaoli Wang; Yijun Luo; Minghuan Li; Hongjiang Yan; Mingping Sun; Tingyong Fan
Journal:  Oncotarget       Date:  2017-01-17

8.  Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients.

Authors:  Guangyan Cheng; Fei Liu; Xinyu Niu; Qigen Fang
Journal:  Cancer Manag Res       Date:  2019-03-21       Impact factor: 3.989

9.  Sentinel lymph node biopsy in cN0 neck management of parotid cancer.

Authors:  Wenting Pan; Kai Ba; Xingyu Niu; Fei Liu; Qigen Fang
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

10.  Contemporary Management of Benign and Malignant Parotid Tumors.

Authors:  Jovanna Thielker; Maria Grosheva; Stephan Ihrler; Andrea Wittig; Orlando Guntinas-Lichius
Journal:  Front Surg       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.